FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110937140> ?p ?o ?g. }

• W2110937140 endingPage "1341" @default.
• W2110937140 startingPage "1337" @default.
• W2110937140 abstract "We examined whether a pretreatment with formoterol, oxitropium bromide, or salmeterol might modify the dose-response curves to inhaled salbutamol in patients with stable and partially reversible chronic obstructive pulmonary disease (COPD). Sixteen outpatients with partially reversible, stable COPD received 24 microg formoterol, 50 microg salmeterol, 200 microg oxitropium bromide, or placebo on four non-consecutive days. Spirometric testing was performed immediately before inhalation of treatment and after 2 h. A dose-response curve to inhaled salbutamol was then constructed using doses of 100, 100, 200 microg and 400 microg--that is, a total cumulative dose of 800 microg. Dose increments were given at 20 min intervals with measurements being made 15 min after each dose. Formoterol, salmeterol, or oxitropium bromide elicited a significant increase in forced expiratory volume in one second (FEV1) compared with placebo (mean differences (L) = placebo 0.05; formoterol 0.34; salmeterol 0.27; oxitropium bromide 0.23). Dose-dependent increases in FEV1 were seen (mean values (L) before salbutamol and after a cumulative dose of 100, 200, 400, and 800 microg = placebo: 1.06, 1.28, 1.35, 1.39, 1.41; formoterol: 1.33, 1.37, 1.41, 1.44, 1.44; salmeterol: 1.30, 1.33, 1.36, 1.39, 1.42; oxitropium bromide: 1.27, 1.34, 1.37, 1.41, 1.40). Statistical analysis revealed no significant differences in FEV1 and forced vital capacity (FVC) responses to salbutamol after therapy with formoterol, salmeterol, or oxitropium bromide compared with placebo. This study clearly shows that a pretreatment with a conventional dose of formoterol, salmeterol, or oxitropium bromide does not preclude the possibility of inducing a further bronchodilation with salbutamol in patients suffering from partially reversible chronic obstructive pulmonary disease." @default.
• W2110937140 created "2016-06-24" @default.
• W2110937140 creator A5020584474 @default.
• W2110937140 creator A5029497117 @default.
• W2110937140 creator A5038202736 @default.
• W2110937140 creator A5038843499 @default.
• W2110937140 creator A5060089859 @default.
• W2110937140 creator A5062907116 @default.
• W2110937140 creator A5067697430 @default.
• W2110937140 date "1998-06-01" @default.
• W2110937140 modified "2023-10-12" @default.
• W2110937140 title "Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD" @default.
• W2110937140 cites W1416625007 @default.
• W2110937140 cites W1916643957 @default.
• W2110937140 cites W1975707290 @default.
• W2110937140 cites W2001143567 @default.
• W2110937140 cites W2011540805 @default.
• W2110937140 cites W2013284507 @default.
• W2110937140 cites W2016083298 @default.
• W2110937140 cites W2023335735 @default.
• W2110937140 cites W2025921150 @default.
• W2110937140 cites W2026338485 @default.
• W2110937140 cites W2035724582 @default.
• W2110937140 cites W2045660738 @default.
• W2110937140 cites W2045827836 @default.
• W2110937140 cites W2050816652 @default.
• W2110937140 cites W2053103871 @default.
• W2110937140 cites W2064439944 @default.
• W2110937140 cites W2064912521 @default.
• W2110937140 cites W2090791054 @default.
• W2110937140 cites W2093056606 @default.
• W2110937140 cites W2108401555 @default.
• W2110937140 cites W2112267419 @default.
• W2110937140 cites W2119921908 @default.
• W2110937140 cites W2132619039 @default.
• W2110937140 cites W2138312725 @default.
• W2110937140 cites W2155682108 @default.
• W2110937140 cites W2169175826 @default.
• W2110937140 cites W2400217583 @default.
• W2110937140 cites W2435561270 @default.
• W2110937140 doi "https://doi.org/10.1183/09031936.98.11061337" @default.
• W2110937140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9657576" @default.
• W2110937140 hasPublicationYear "1998" @default.
• W2110937140 type Work @default.
• W2110937140 sameAs 2110937140 @default.
• W2110937140 citedByCount "39" @default.
• W2110937140 countsByYear W21109371402012 @default.
• W2110937140 countsByYear W21109371402013 @default.
• W2110937140 countsByYear W21109371402014 @default.
• W2110937140 countsByYear W21109371402015 @default.
• W2110937140 crossrefType "journal-article" @default.
• W2110937140 hasAuthorship W2110937140A5020584474 @default.
• W2110937140 hasAuthorship W2110937140A5029497117 @default.
• W2110937140 hasAuthorship W2110937140A5038202736 @default.
• W2110937140 hasAuthorship W2110937140A5038843499 @default.
• W2110937140 hasAuthorship W2110937140A5060089859 @default.
• W2110937140 hasAuthorship W2110937140A5062907116 @default.
• W2110937140 hasAuthorship W2110937140A5067697430 @default.
• W2110937140 hasBestOaLocation W21109371401 @default.
• W2110937140 hasConcept C126322002 @default.
• W2110937140 hasConcept C142724271 @default.
• W2110937140 hasConcept C204787440 @default.
• W2110937140 hasConcept C27081682 @default.
• W2110937140 hasConcept C2776042228 @default.
• W2110937140 hasConcept C2776136866 @default.
• W2110937140 hasConcept C2776719499 @default.
• W2110937140 hasConcept C2776780178 @default.
• W2110937140 hasConcept C2776954882 @default.
• W2110937140 hasConcept C2777394947 @default.
• W2110937140 hasConcept C2779871671 @default.
• W2110937140 hasConcept C2781018748 @default.
• W2110937140 hasConcept C2909086917 @default.
• W2110937140 hasConcept C42219234 @default.
• W2110937140 hasConcept C71924100 @default.
• W2110937140 hasConceptScore W2110937140C126322002 @default.
• W2110937140 hasConceptScore W2110937140C142724271 @default.
• W2110937140 hasConceptScore W2110937140C204787440 @default.
• W2110937140 hasConceptScore W2110937140C27081682 @default.
• W2110937140 hasConceptScore W2110937140C2776042228 @default.
• W2110937140 hasConceptScore W2110937140C2776136866 @default.
• W2110937140 hasConceptScore W2110937140C2776719499 @default.
• W2110937140 hasConceptScore W2110937140C2776780178 @default.
• W2110937140 hasConceptScore W2110937140C2776954882 @default.
• W2110937140 hasConceptScore W2110937140C2777394947 @default.
• W2110937140 hasConceptScore W2110937140C2779871671 @default.
• W2110937140 hasConceptScore W2110937140C2781018748 @default.
• W2110937140 hasConceptScore W2110937140C2909086917 @default.
• W2110937140 hasConceptScore W2110937140C42219234 @default.
• W2110937140 hasConceptScore W2110937140C71924100 @default.
• W2110937140 hasIssue "6" @default.
• W2110937140 hasLocation W21109371401 @default.
• W2110937140 hasLocation W21109371402 @default.
• W2110937140 hasOpenAccess W2110937140 @default.
• W2110937140 hasPrimaryLocation W21109371401 @default.
• W2110937140 hasRelatedWork W1968408828 @default.
• W2110937140 hasRelatedWork W2009147527 @default.
• W2110937140 hasRelatedWork W2073776604 @default.
• W2110937140 hasRelatedWork W2082561042 @default.

• next